Nathaniel Henning
Affiliations: | University of California, Berkeley, Berkeley, CA, United States |
Google:
"Nathaniel Henning"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Henning NJ, Manford AG, Spradlin JN, et al. (2023) Correction to "Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications". Journal of the American Chemical Society. 145: 21142 |
| Moon P, Zammit C, Shao Q, et al. (2023) Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors. Chembiochem : a European Journal of Chemical Biology. e202300116 |
| Du G, Jiang J, Henning NJ, et al. (2022) Exploring the target scope of KEAP1 E3 ligase-based PROTACs. Cell Chemical Biology |
| Boike L, Henning NJ, Nomura DK. (2022) Advances in covalent drug discovery. Nature Reviews. Drug Discovery |
| Henning NJ, Boike L, Spradlin JN, et al. (2022) Deubiquitinase-targeting chimeras for targeted protein stabilization. Nature Chemical Biology |
| Henning NJ, Manford AG, Spradlin JN, et al. (2022) Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications. Journal of the American Chemical Society. 144: 701-708 |
| Du G, Jiang J, Wu Q, et al. (2021) Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2. Angewandte Chemie (International Ed. in English) |
| Boike L, Cioffi AG, Majewski FC, et al. (2020) Discovery of a Functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYC. Cell Chemical Biology |
| Du G, Rao S, Gurbani D, et al. (2020) Structure-based design of a potent and selective covalent inhibitor for SRC kinase that targets a p-Loop cysteine. Journal of Medicinal Chemistry |